Agenda – 2nd Real-World Evidence Forum

  • Day One
  • Day Two

Day One

 Monday, July 16

9:15AM – 10:00AM

Keynote Advance Healthcare Innovation Using Real- World Evidence
Christopher Boone, Ph.D., FACHE, Vice President, Real- World Data and Analytics Center of Excellence, Patient and Health Impact, PFIZER


10:00AM – 10:45AM

Achieving Data Standardization with the Adoption and Use of a Single Standard Across an Entire RWE Ecosystem
Victoria Gamerman, Head of Health Informatics and Analytics, BOEHRINGER INGELHEIM

10:45AM – 11:15AM

Networking Break

11:15AM – 12:15PM

Incorporate, Manage, and Utilize Digital Health Tools to Generate High-Quality RWE
Shahed Iqbal, Director, Epidemiology, DAIICHI SANKYO
P. David Gee, Assistant Director, Research Analytics and Data Science, DUKE CLINICAL RESEARCH INSTITUTE

12:15PM – 1:15PM


1:15PM – 2:00PM

Accelerate the Improved Patient Journey Through Clinical Trial Development and RWE
Jane Fang, Research and Development Information Head for Clinical Biologics, ASTRAZENECA/MEDIMMUNE

2:00PM – 2:45PM

Clinical Data for Translational Medicine: A Machine Learning Approach
Raj Bandaru, Analytics and Informatics Services, SANOFI

2:45PM – 3:15PM

Networking Break


3:15PM – 4:00PM

Discuss a Global Approach to Real-World Evidence
Bart Barefoot, Director, VEO and RWE Policy, Advocacy, and External Collaboration, GLAXOSMITHKLINE

4:00PM – 4:45PM

Interpret FDA Guidance: How the Agency May Use Data to Support Regulatory Decision-Making
Nneka Onwudiwe, Pharm.D., Ph.D., MBA, PRO/ PE Regulatory Review Officer, FOOD AND DRUG ADMINISTRATION

4:45PM – 5:30PM

Guidance on Transparency and Reproducibility of Real-World Evidence?
Elizabeth (Betsy) MacLean, Pharm. D., PhD., Senior Director, Customer Projects FBM Liaison, U.S. Medical Affairs, Pfizer

5:30PM –

End of Day One

Day Two

 Tuesday, July 17


9:15AM – 10:00AM

Keynote Understand the Role of RWE in Driving Healthcare Reform and Decision-Making
Melinda Hanisch, Director, Research Dissemination, Real- World Evidence and Global Market Access Policy Expert, MERCK

10:00AM – 10:45AM

Utilize Medical Affairs Channels to Inform Clinical Practitioners of RWE
Poushali Mukherjea, Ph.D., Executive Director, Medical Affairs, BRISTOL-MYERS SQUIBB

10:45AM – 11:15AM

Networking Break


11:15AM – 12:00PM

Impact of Artificial Intelligence in Real-World Evidence
Jyotsna Kasturi, Real-World Evidence Statistics Lead, Associate Director, TEVA PHARMACEUTICALS

12:00PM – 1:00PM


1:00PM – 1:45PM

Create Higher Quality and Adaptable Evidence Packages of Real-World Evidence
Dr. Jefferson Tea, Vice President, Medical and Scientific Affairs, TAKEDA PHARMACEUTICALS

1:45PM – 2:30PM

Drive Insights Across the Value Chain Using Real-World Evidence
Patrick Loerch, Sr. Director, Data Sciences, CELGENE CORP